Information  X 
Enter a valid email address

MaxCyteIncStk $0.01DI (MXCT)

Date Time Source Announcement
16 Nov 2018 7:00 am
RNS
Webinar: non-viral cell engineering
14 Nov 2018 7:00 am
RNS
Clinical and Commercial License Agreement
12 Nov 2018 7:00 am
RNS
MaxCyte Announces Research Agreement with Kite
09 Nov 2018 7:00 am
RNS
Expansion of CRISPR Commercial License Agreement
31 Oct 2018 4:25 pm
RNS
Result of AGM
10 Oct 2018 7:00 am
RNS
Dosing Begins in First Clinical Trial of MCY-M11
08 Oct 2018 7:00 am
RNS
Notice of AGM
24 Sep 2018 7:00 am
RNS
Results for the Half Year ended 30 June 2018
10 Sep 2018 7:00 am
RNS
Grant of Options
03 Sep 2018 7:00 am
RNS
Notice of Half Year Results
26 Jul 2018 5:33 pm
RNS
Director/PDMR Shareholding
16 Jul 2018 7:00 am
RNS
FDA IND Clearance for First Clinical Programme
  7:00 am
RNS
Trading Update
11 Jun 2018 7:00 am
RNS
MaxCyte & NIH enter CRADA for Sickle Cell Disease
21 May 2018 7:00 am
RNS
Preclinical Results at ASGCT Annual Meeting
30 Apr 2018 7:00 am
RNS
Notice of AGM and Annual Report
25 Apr 2018 7:00 am
RNS
CMO Appointment
04 Apr 2018 7:00 am
RNS
Final Results for Year Ended 31 December 2017
15 Mar 2018 7:00 am
RNS
Notice of Full Year Results
28 Feb 2018 5:00 pm
RNS
Director/PDMR Shareholding
15 Feb 2018 7:00 am
RNS
Grant of Options
13 Feb 2018 7:00 am
RNS
Dr Richard Douglas Joins MaxCyte Board
01 Feb 2018 4:06 pm
RNS
Block listing Interim Review
23 Jan 2018 1:32 pm
RNS
Total Voting Rights
22 Jan 2018 7:00 am
RNS
Trading Update
12 Jan 2018 5:13 pm
RNS
Total Voting Rights
30 Nov 2017 3:26 pm
RNS
Total Voting Rights
31 Oct 2017 12:47 pm
RNS
Result of AGM
16 Oct 2017 7:00 am
RNS
Declaration of Audit Remuneration
05 Oct 2017 6:32 pm
RNS
Holding(s) in Company
  6:31 pm
RNS
Holding(s) in Company
28 Sep 2017 5:15 pm
RNS
Notice of AGM
19 Sep 2017 7:00 am
RNS
Interim Results
25 Aug 2017 7:00 am
RNS
Notice of Half Year Results
20 Jul 2017 6:02 pm
RNS
Grant of Options
12 Jul 2017 7:00 am
RNS
Trading Update
06 Jun 2017 7:00 am
RNS
Research & Development Agreement with NIAID
31 May 2017 4:30 pm
RNS
Total Voting Rights
02 May 2017 1:42 pm
RNS
Block Listing Application
25 Apr 2017 6:27 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Presentation of Positive Preclinical Data
20 Apr 2017 6:00 pm
RNS
Result of Special Meeting and Issue of Equity
13 Apr 2017 1:00 pm
RNS
Notice of AGM and 2016 Annual Report and Accounts
31 Mar 2017 12:40 pm
RNS
Results of Placing
  7:00 am
RNS
Proposed Placing to raise up to approx. �20.0m
20 Mar 2017 7:00 am
RNS
Full Year Results
14 Mar 2017 7:00 am
RNS
CRISPR THERAPEUTICS/CASEBIA COMMERCIAL LICENSE
02 Mar 2017 7:00 am
RNS
MaxCyte to Present Pre-Clinical CARMA Data at AACR
01 Mar 2017 7:00 am
RNS
Notice of Full Year Results
24 Jan 2017 7:00 am
RNS
Trading Update
12 Jan 2017 7:00 am
RNS
Study Published in Science Translational Medicine
03 Jan 2017 2:49 pm
RNS
Issue of Equity from exercise of Share Options
21 Dec 2016 7:00 am
RNS
MaxCyte Announces Collaboration to Advance CARMA
06 Dec 2016 9:34 am
RNS
Issue of Equity from exercise of Share Options
27 Oct 2016 7:00 am
RNS
Result of Annual General Meeting
21 Oct 2016 7:43 am
RNS
Director/PDMR Shareholding
28 Sep 2016 6:00 pm
RNS
Grant of Options
27 Sep 2016 7:00 am
RNS
Financial Results for Six Months ended 30 June 16
19 Sep 2016 5:00 pm
RNS
Notice of AGM
06 Sep 2016 7:00 am
RNS
Notice of Interim Results
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t